Finding Trials with CancerBot
Jan 6, 2025
When you first sign up the first step is to describe yourself and your disease a bit to help CancerBot suggest some trials. In the example below the user has entered her age, gender, disease (multiple myeloma) and stage.

As shown in the image above, CancerBot then suggests 15 Eligible trials and 46 Potential trials. CancerBot will help us get more of those Potential trials to be Eligible. This is a key feature for CancerBot because getting accurate current vitals typically requires cost and effort to get tests. We can now just focus on the measurements that truly expand our trial opportunities.
The first thing it suggests is to fill in ECOG Performance Status to get 15 more trials. Then CancerBot suggests that several “behavior” attributes to be completed: “consent capability”, “caregiver availability” and “contraceptive” usage.

Setting these dropdowns all to Yes leaves us this list of 57 Eligible trials and 5 Potential trials. Now we are prompted to fill in monoclonal protein serum, monoclonal protein urine, pulmonary function test result, and ejection fraction.

After filling out that data, we now have 58 eligible trials and no additional potential trials. We can view them one by one to see which are the best fits, although we will be eligible for all. If we want to narrow down the trial search further we can search by the intervention (looking for a particular drug name for example) or (once we enter our zip code) perform a distance search to get trials near us.
I am interested in the teclistamab vs. talquetamab trial listed third.

Clicking the Apply button sends our valid eligibility criteria and the rest of our lab values to the researcher (we can add text to the outreach message).
Turning frustration into innovation
After being diagnosed with follicular lymphoma, AI tech entrepreneur Adam Blum assumed he could easily find cutting-edge treatment options. Instead, he faced resistance from doctors and an exhausting search process. Determined to fix this, he built CancerBot—an AI-powered tool that makes clinical trials more accessible, helping patients find potential life-saving treatments faster.